Related references
Note: Only part of the references are listed.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery
H. Boon et al.
DIABETOLOGIA (2007)
Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin
Matteo Monami et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
Kjeld Hermansen et al.
DIABETES CARE (2006)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The UGDP controversy - thirty-four years of contentious ambiguity laid to rest
TB Schwartz et al.
PERSPECTIVES IN BIOLOGY AND MEDICINE (2004)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Combination of insulin and metformin in the treatment of type 2 diabetes
MG Wulffelé et al.
DIABETES CARE (2002)
Sulfonylurea inadequacy - Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
A Wright et al.
DIABETES CARE (2002)
Insulin therapy in type 2 diabetes
S Mudaliar et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2001)
Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
A Holstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Combination therapies with insulin in type 2 diabetes
H Yki-Järvinen
DIABETES CARE (2001)